Conestoga Capital Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.64M | Hold |
27,455
| – | – | 0.02% | 74 |
|
2025
Q1 | $1.44M | Hold |
27,455
| – | – | 0.02% | 75 |
|
2024
Q4 | $1.51M | Sell |
27,455
-100
| -0.4% | -$5.5K | 0.02% | 77 |
|
2024
Q3 | $1.39M | Hold |
27,555
| – | – | 0.02% | 79 |
|
2024
Q2 | $1.21M | Sell |
27,555
-100
| -0.4% | -$4.39K | 0.02% | 86 |
|
2024
Q1 | $1.22M | Buy |
27,655
+11,875
| +75% | +$522K | 0.02% | 86 |
|
2023
Q4 | $749K | Buy |
+15,780
| New | +$749K | 0.01% | 104 |
|
2017
Q1 | – | Sell |
-504,600
| Closed | -$5.6M | – | 117 |
|
2016
Q4 | $5.6M | Sell |
504,600
-68,285
| -12% | -$758K | 0.37% | 48 |
|
2016
Q3 | $9.73M | Buy |
572,885
+285,050
| +99% | +$4.84M | 0.67% | 46 |
|
2016
Q2 | $6.26M | Sell |
287,835
-33,175
| -10% | -$722K | 0.46% | 47 |
|
2016
Q1 | $6.15M | Buy |
321,010
+181,205
| +130% | +$3.47M | 0.42% | 45 |
|
2015
Q4 | $3.92M | Buy |
+139,805
| New | +$3.92M | 0.32% | 46 |
|